[ALNY] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
13-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -32.44%
YoY- -30.62%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 335,035 258,535 163,562 71,681 21,033 37,924 17,454 63.59%
PBT -207,021 -260,302 -243,599 -276,583 -211,080 -142,227 -112,934 10.62%
Tax 472 -1,842 -59 -398 361 -7,949 -5,217 -
NP -207,493 -258,460 -243,540 -276,185 -211,441 -142,227 -112,934 10.66%
Tax Rate - - - - - - - -
Total Cost 542,528 516,995 407,102 347,866 232,474 180,151 130,388 26.80%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -61.93 -99.97 -148.90 -385.30 -1,005.28 -375.03 -647.04 -32.35%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -1.68 -2.16 -2.09 -2.47 -2.09 -1.48 -1.32 4.09%
EPS Diluted -1.68 -2.16 -2.09 -2.47 -2.09 -1.48 -1.32 4.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.